- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Thermo Fisher to Close Franklin, Mass. Site, Cut Up to 80 Jobs | 6 | Contract Pharma | ||
| Mo | Thermo Fisher trims Massachusetts headcount with Franklin site closure | 5 | FiercePharma | ||
| So | Notable healthcare headlines for the week: UnitedHealth, Novo Nordisk, and Thermo Fisher in focus | 64 | Seeking Alpha | ||
| Fr | Thermo Fisher stock rating reiterated at Buy by Stifel on solid 2025 finish | 9 | Investing.com | ||
| Fr | Stifel bestätigt Kaufempfehlung für Thermo Fisher nach starkem Jahresabschluss 2025 | 22 | Investing.com Deutsch | ||
| Fr | Thermo Fisher stock price target lowered to $683 by TD Cowen on conservative guidance | 9 | Investing.com | ||
| 29.01. | Thermo Fisher signals 2026 revenue guidance of up to $47.2B with 6%-8% EPS growth while advancing AI and strategic acquisitions | 23 | Seeking Alpha | ||
| THERMO FISHER SCIENTIFIC INC CDR Aktie jetzt für 0€ handeln | |||||
| 29.01. | Thermo Fisher higher after Q4 beat | 41 | Seeking Alpha | ||
| 29.01. | Thermo Fisher Scientific Earnings Up In Q4 | 484 | AFX News | WASHINGTON (dpa-AFX) - Thermo Fisher Scientific Inc. (TMO), a life sciences and clinical research company, on Thursday reported that net income increased in the fourth quarter compared with... ► Artikel lesen | |
| 29.01. | Thermo Fisher Scientific Announces Increase In Q4 Bottom Line | 318 | AFX News | WASHINGTON (dpa-AFX) - Thermo Fisher Scientific (TMO) revealed a profit for its fourth quarter that Increases, from the same period last yearThe company's bottom line totaled $1.964 billion... ► Artikel lesen | |
| 29.01. | Earnings Snapshot: Thermo Fisher Scientific tops Q4 estimates; to provide FY26 guidance during call | 22 | Seeking Alpha | ||
| 29.01. | Thermo Fisher Scientific Non-GAAP EPS of $6.57 beats by $0.12, revenue of $12.21B beats by $320M | 10 | Seeking Alpha | ||
| 29.01. | THERMO FISHER SCIENTIFIC INC. - 8-K, Current Report | 5 | SEC Filings | ||
| 28.01. | A Glimpse of Thermo Fisher Scientific's Earnings Potential | 5 | Benzinga.com | ||
| 28.01. | Thermo Fisher Scientific Q4 2025 Earnings Preview | 31 | Seeking Alpha | ||
| 27.01. | BlackRock, Thermo Fisher And More On CNBC's 'Final Trades' | 16 | Benzinga.com | ||
| 23.01. | $1000 Invested In Thermo Fisher Scientific 20 Years Ago Would Be Worth This Much Today | 8 | Benzinga.com | ||
| 23.01. | Can Specialty Diagnostics Strength Drive Thermo Fisher's Q4 Earnings? | 14 | Zacks | ||
| 21.01. | P/E Ratio Insights for Thermo Fisher Scientific | 7 | Benzinga.com | ||
| 21.01. | NSE - THERMO FISHER SCIENTIFIC INC. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | 8 | SEC Filings |
1 2 3 4 5 Weiter >>
188 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| THERMO FISHER | 477,10 | -0,37 % | Thermo Fisher Scientific Earnings Up In Q4 | WASHINGTON (dpa-AFX) - Thermo Fisher Scientific Inc. (TMO), a life sciences and clinical research company, on Thursday reported that net income increased in the fourth quarter compared with... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 41,730 | -2,50 % | DAX-Konzern Siemens Healthineers legt Zahlen vor | Siemens Healthineers startet solide ins neue Geschäftsjahr und bestätigt den Jahresausblick, wird aber vom schwachen Diagnostikgeschäft in China gebremst. Der DAX-Konzern Siemens Healthineers ist mit... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,320 | 0,00 % | Alignment Healthcare Reports 31% Year-Over-Year Membership Growth to 275,300 as of Jan. 1, 2026 | Guides year-end 2026 health plan membership range of 290,000 to 296,000. Announces its expectation that consensus adjusted EBITDA of approximately $145 million in 2026 will be within its full-year... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,360 | +0,22 % | Fresenius Medical Care: Ein Neuanfang nach turbulenten Zeiten? | ||
| PROCEPT BIOROBOTICS | 28,940 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| FRESENIUS | 48,580 | -1,66 % | Fresenius: Analysten bleiben bullish - jetzt einsteigen? | Der charttechnische Ausflug der Aktie des Gesundheitskonzerns Fresenius über die Marke von 50 Euro war nicht nachhaltig. Inzwischen notiert der DAX-Wert wieder deutlich darunter. Geht es nach dem Gros... ► Artikel lesen | |
| BILLIONTOONE | 83,51 | +0,99 % | BillionToOne, Inc.: BillionToOne Provides Guidance for 2026 | MENLO PARK, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| PROGYNY | 22,800 | 0,00 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| CONCENTRA GROUP | 22,940 | 0,00 % | Concentra Group Holdings Parent, Inc. - 8-K, Current Report | ||
| RXSIGHT | 7,940 | -4,80 % | RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer | ALISO VIEJO, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following... ► Artikel lesen | |
| ANTERIS TECHNOLOGIES GLOBAL | 5,570 | 0,00 % | ANTERIS TECHNOLOGIES GLOBAL CORP.: Statement of CDIs on issue - AVR | ||
| PRIVIA HEALTH GROUP | 22,010 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 6,935 | 0,00 % | LifeStance Health Gr Stock: A Deep Dive Into Analyst Perspectives (6 Ratings) | ||
| CARL ZEISS MEDITEC | 27,580 | -0,36 % | BARCLAYS stuft CARL ZEISS MEDITEC AG auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Carl Zeiss Meditec von 49 auf 32 Euro gesenkt und die Aktien von "Overweight" auf "Equal Weight" abgestuft. Nur... ► Artikel lesen | |
| CERIBELL | 20,150 | 0,00 % | Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution | SUNNYVALE, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with... ► Artikel lesen |
Das Unternehmen THERMO FISHER SCIENTIFIC INC CDR kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 12,100 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu THERMO FISHER SCIENTIFIC INC CDR finden Sie auf Wallstreet Online.